REFERENCES
- Hasan A, Fortune F, Wilson A, et al. Role of γ δ T cells in the pathogenesis and diagnosis with Behçet's disease. Lancet 1996; 347: 789–794, [INFOTRIEVE], [CSA]
- Frassanito M A, Dammacco R, Cafforio P, Dammacco F. Th1 polarization of the immune response in Behçet's disease. A putative pathogenic role of interleukin-12. Arthritis Rheum 1999; 42: 1967–1974, [INFOTRIEVE], [CSA], [CROSSREF]
- Takeno M, Kariyone A, Yamashita N, et al. Excessive function of peripheral blood neutrophils from patients with Behçet's disease and from HLA-B51 transgenic mice. Arthritis Rheum 1995; 38: 426–433, [INFOTRIEVE], [CSA]
- Yu H G, Lee D S, Seo J M, et al. The numbers of CD8+ T cells and NKT cells increases in the aqueous humor of patients with Behçet's uveitis. Clin Exp Immunol 2004; 137: 437–443, [INFOTRIEVE], [CSA], [CROSSREF]
- Lanier L L, Testi R, Bindl J, Phillips J H. Identification of Leu-19 (CD56) leukocyte differentiation antigen and neural cell adhesion molecule. J Exp Med 1989; 169: 2233–2238, [INFOTRIEVE], [CSA], [CROSSREF]
- Ou D, Metzger D L, Wang X, Pozzilli P, Tingle A J. β-cell antigen-specific CD56+ NKT cells from type 1 diabetic patients: autoaggressive effector T cells damage human CD56+ β cells by HLA-restricted and non-HLA-restricted pathways. Hum Immunol 2002; 63: 256–270, [INFOTRIEVE], [CSA], [CROSSREF]
- Satoh M, Seki S, Hashimoto W, et al. Cytotoxic γ δ or α β T cells with a natural killer cell marker, CD56, induced from human peripheral blood lymphocytes by a combination of IL-12 and IL-2. J Immunol 1996; 157: 3886–3894, 1996[INFOTRIEVE], [CSA]
- Pittet M J, Speiser D E, Valmori D, Cerottini J, Romero P. Cutting edge: Cytolytic effector function in human circulating CD8+ T cells closely correlates with CD56 surface expression. J Immunol 2000; 164: 1148–1152, [INFOTRIEVE], [CSA]
- Ohkawa T, Seki S, Dobashi H, et al. Systematic characterization of human CD8+ T cells with natural killer cell markers in comparison with natural killer cells and normal CD8+ T cells. Immunology 2001; 103: 281–290, [INFOTRIEVE], [CSA], [CROSSREF]
- Ahn J K, Chung H, Lee D S, Yu Y S, Yu H G. CD8brightCD56+ T cells are cytotoxic effectors in patients with active Behçet's uveitis. J Immunol 2005; 175: 6133–6142, [INFOTRIEVE], [CSA]
- Dick A D, Azim M, Forrester J V. Immunosuppessive therapy for chronic uveitis, optimizing therapy with steroid and cyclosporine A. Br J Ophthalmol 1997; 81: 1107–1112, [INFOTRIEVE], [CSA]
- Whitcup S M, Salvo E C, Jr., Nussenblatt R B. Combined cyclosporine and corticosteroids therapy for sight-threatening uveitis in Behcet's disease. Am J Ophthalmol 1994; 118: 39–45, [INFOTRIEVE], [CSA]
- Ahn J K, Seo J M, Yu J, et al. Down-regulation of IFN-γ-producing CD56+ T cells after combined low dose cyclosporine and prednisone treatment in active Behcet's uveitis patients. Invest Ophthalmol Vis Sci 2005; 46: 2458–2464, [INFOTRIEVE], [CSA], [CROSSREF]
- International Study Group for Behçet's disease. Criteria for diagnosis of Behçet's disease. Lancet 1990; 335: 1078–1080, [CSA]
- Bloch-Michel E, Nussenblatt R B. International Uveitis Study Group recommendations for the evaluation of intraocular inflammatory disease. Am J Ophthalmol 1987; 103: 235–239, [CSA]
- Kataoka T, Shinohara N, Takayama H, et al. Concanamycin A, a powerful tool for characterization and estimation of contribution of perforin-and fas-based lytic pathways in cell-mediated cytotoxicity. J Immunol 1996; 156: 3678–3686, [INFOTRIEVE], [CSA]
- Ina K, Kusugami K, Shimada M, et al. Suppressive effects of cyclosporine A on neutrophils and T cells may be related to therapeutic benefits in patients with steroid-resistant ulcerative colitis. Inflamm Bowel Dis 2002; 8: 1–9, [INFOTRIEVE], [CSA], [CROSSREF]
- Zhan X, Brown B, Slobod K S, Hurwits J L. Inhibition of ex vivo-expanded cytotoxic T lymphocytes function by high-dose cyclosporine. Transplantation 2003; 76: 739–740, [INFOTRIEVE], [CSA], [CROSSREF]
- Koenen H J, Michielson E C, Verstappen J, Fasses E, Joosten I. Superior T-cell suppression by rapamycin and FK506 over rapamycin and cyclosporine A because of abrogated cytotoxic T lymphocyte induction, impaired memory responses, and persistent apoptosis. Transplantation 2003; 75: 1581–590, [INFOTRIEVE], [CSA], [CROSSREF]
- Strauss G, Osen W, Debatin K M. Induction of apoptosis and modulation of activation and effector function in T cells by immuosuppressive drugs. Clin Exp Immunol 2002; 128: 255–66, [INFOTRIEVE], [CSA], [CROSSREF]
- Dengler T J, Pober J S. Human vascular endothelial cells stimulate memory but not naïve CD8+ T cells to differentiate into CTL, retaining an early activation phenotype. J Immunol 2000; 164: 5146–5155, [INFOTRIEVE], [CSA]
- Pervin K, Childerstone A, Shinnick T, et al. T cell epitope expression of mycobacterial and homologous human 65-kilodalton heat shock protein peptides in short term cell lines from patients with Behçet's disease. J Immunol 1993; 151: 2273–2282, [INFOTRIEVE], [CSA]
- De Smet M D, Dayan M. Propsective determination of T-cell responses to S-antigen in Behçet's disease patients and controls. Invest Ophthalmol Vis Sci 2000; 41: 3480–3484, [INFOTRIEVE], [CSA]
- Lehner T, Lavery E, Smith R, et al. Association between the 65-kilodalton heat shock protein, Streptococcus sanguis, and the corresponding antibodies in Behçet's disease. Infect Immun 1991; 59: 1434–1441, [INFOTRIEVE], [CSA]
- Mizuki N, Ota M, Katsuyama Y, et al. Localization of the pathogenic gene of Behçet's disease by microsatellite analysis of three different populations. Invest Ophthalmol Vis Sci 2000; 41: 3702–3708, [INFOTRIEVE], [CSA]
- Yasuoka H, Okazaki Y, Kawakami Y, et al. Autoreactive CD8+ cytotoxic T lymphocytes to major histocompatibility complex class I chain-related gene A in patients with Behçet's disease. Arthritis Rheum 2004; 50: 3658–3662, [INFOTRIEVE], [CSA], [CROSSREF]
- Oehen S, Brduscha-Riem K. Differentiation of naïve CTL to effector and memory CTL: correlation of effector function with phenotype and cell division. J Immunol 1998; 161: 5338–5346, [INFOTRIEVE], [CSA]
- Tomiyama H, Matsuda T, Takiguchi M. Differentiation of human CD8+ T cells from a memory to memory/effector phenotype. J Immunol 2002; 168: 5538–5550, [INFOTRIEVE], [CSA]
- Houman H, Hamzaoui A, Ghorbal I B, et al. Tc1/Tc2 ratio in the inflammatory process in patients with Behçet's disease. Mediat Inflamm 2004; 13: 247–253, [CSA], [CROSSREF]
- McMahon C W, Raulet D H. Expression and function of NK receptors in CD8+ T cells. Curr Opin Immunol 2001; 13: 465–470, [INFOTRIEVE], [CSA], [CROSSREF]
- Mingari M C, Ponte M, Bertone S, et al. HLA class I-specific inhibitory receptors in human T lymphocytes: interleukin-15 induced expression of CD94/NKG2A in superantigen-or alloantigen-activated CD8+ T cells. Proc Natl Acad Sci USA 1998; 95: 1172–1177, [INFOTRIEVE], [CSA], [CROSSREF]
- Groh V, Rhinehart R, Randolph-Habecker J, et al. Costimulation of CD8 α β T cells by NKG2D via engagement by MIC induced on virus-infected cells. Nat Immunol 2001; 2: 255–260, [INFOTRIEVE], [CSA], [CROSSREF]
- Snyder M R, Weyand C M, Goronzy J J. The double life of NK receptors: stimulation or co-stimulation?. Trends Immunol 2004; 25: 25–32, [INFOTRIEVE], [CSA], [CROSSREF]
- Suzuki Y, Hoshi K, Matsuda T, Mizushima Y. Increased peripheral blood gammadelta T cells and natural killer cells in Behçet's disease. J Rheumatol 1992; 588–592, [CSA]
- Takata H, Tomiyama H, Fujiwara M, Kobayashi N, Takiguchi M. Cutting edge: expression of chemokine receptors CXCR1 on human effector CD8+ T cells. J Immunol 2004; 173: 2231–2235, [INFOTRIEVE], [CSA]
- Hess C, Means T K, Autissier P, et al. IL–8 responsiveness defines a subset of CD8 T cells poised to kill. Blood 2004; 104: 3463–3471, [INFOTRIEVE], [CSA], [CROSSREF]
- Russell J H, Ley T J. Lymphocyte-mediated cytotoxicity. Annu Rev Immunol 2002; 20: 324–370, [CSA], [CROSSREF]
- Cherin P, Herson S, Crevon M C, et al. Mechanisms of lysis by activated cytotoxic cells expressing perforin and granzyme B genes and the protein TIA-1 in muscle biopsies of myositis. J Rheumatol 1996; 23: 1135–1142, [INFOTRIEVE], [CSA]
- Lu P, Garcia-Sanz J A, Lichtenheld M G, Podack E R. Perforin expression in human peripheral blood mononuclear cells. Definition of an IL-2-independent pathway of perforin induction of CD8+ T cells. J Immunol 1992; 148: 3354–3360, [INFOTRIEVE], [CSA]